We describe a simple, rapid and sensitive homogeneous immunoassay for urinary retinol-binding protein (RBP) using latex particle-enhanced turbidimetric immunoassay. Rabbit anti-human RBP is covalently coupled to 40 nm latex particles and the assay performed on the IL Monarch 2000 centrifugal analyser, with a 20 pL sample volume and the reaction monitored at 340 nm over an 8 min period. The assay range is 0-6 mg/L with a detection limit of 25 pg/L. The within and between assay coefficients of variation are less than 1.5% and less than 2 -5 % , respectively.
Retinol binding protein (RBP) is a small (21 000D) transport protein for vitamin A, which forms a complex with pre-albumin in blood but loses its affinity for prealbumin once the vitamin has been delivered to the target cells. The free RBP molecule is then rapidly filtered at the glomerulus and catabolized in the renal tubules after reabsorption by the proximal tubular cells. Other low molecular weight proteins like a,-microglobulin (a,m) and P,-microglobulin (&m) are handled by the kidney in a similar manner. In kidney disease with prevailing tubular changes these proteins are not reabsorbed and appear in the urine2
Currently the most widely used test for the early detection of tubular proteinuria is the determination of urinary f12m excretion. However, the instability of this protein in acid urine is a major d r a~b a c k .~ Bernard et al. compared the urinary excretion of RBP and P2m in patients with renal disease and showed that, in the absence of a pH effect, the sensitivity and specificity of both proteins as indices of tubular function are very similar.4 Therefore in view of its greater stability in acid urine, the determination of urinary RBP may be a more practical index of proximal tubular function.
Various methods for RBP measurement have been described including radial immunodiffusion Correspondence: Dr D J Newman.
(RID), radioimmunoassay (RIA), immunonephelometry and enzyme linked immunosorbent assay (ELISA).5-'o Bernard et al. have used a latex particle enhanced assay to measure RBP in serum and urine but used a very high sample dilution and encountered stability problems with the antibody-coated particle. This was probably due to the antibody being adsorbed onto the surface of the latex particles rather than covalently bound. The working reagent after being resuspended in glycine buffered saline pH 10, with addition of bovine serum albumin before use, was stable for only 3 h. This method also employs a particle counter to achieve a sensitive standard curve, which is expensive and not commonly available in most laboratories. Here, we describe the development and validation of a rapid latex particle-enhanced turbidimetric immunoassay (PETIA) for RBP in urine that can be adapted for use on most automated instruments in the clinical laboratory. The antibody coated particle is stable, does not require special storage conditions, and is therefore immediately available for use.
MATERIALS AND METHODS

Latex particledantibody
The latex particles were provided by E I DuPont de Nemours (Delaware, USA), as a 10% (w/v) suspension of 40 nm diameter particles. These contained a polyvinyl naphthalene core, with a 407 chemically reactive shell of chloromethylstyrene (CMST).'Z Particles were covalently coupled t o affinity purified rabbit immunoglobulins to human RBP, a gift from Dakopatts (Copenhagen, Denmark. Code No: A 040).
Protocol for covalent coupling
Particles and antibody were first dialysed separately overnight against 15 mM sodium phosphate buffer p H 7.4 at room temperature. They were diluted in coupling buffer (15 mM phosphate buffer pH 7.4, containing 0.5 mL/L GAFAC RE610 surfactant-GAFAC Corporation, Wythenshawe, Manchester, UK), to give a 1% (w/v) particle solution and an appropriate antibody concentration. The antibody and particles were mixed 1 : 1 and incubated overnight at 37°C with constant shaking on an incubator/ shaker (Infors, Crewe, UK). Coupled particles were separated by centrifugation using a Sorvall RC-5B refrigerated superspeed centrifuge (Du Pont (UK) Ltd, Stevenage, UK) at 40000g for 1 h, and washed four times in 50mM glycine buffer pH 7.5. The particles were then stored at 4°C in 500 mM glycine buffer pH 7.5, containing 0.5 mL/L GAFAC and 1 g/L sodium azide. The reagent was sonicated for two bursts of 60s at a frequency of 23 kHz and amplitude setting of 22 microns, using a MSE Soniprep 150 (MSE Instruments, Crawley, UK), before preparing the working particle reagent in 5 mM glycine buffer pH 7 -5 .
Standards
The RBP standard, a gift from SCIPAC (Sittingbourne, UK. Code No: P124-1) was diluted in saline/Brij solution and stored at 4°C (9 g/L sodium chloride containing 0-01 g/L Brij 35, Sigma UK Ltd, Poole, UK).
Final assay buffer 340 mmol/L borate/KCI pH 10.0 containing 67g/L PEG 8000 (Union Carbide, Danbury, USA), 10 g/L bovine serum albumin (Sigma UK Ltd, Poole, UK) unless otherwise stated, and 1 g/L sodium azide.
Procedure
All reactions were performed on a Monarch 2000 centrifugal analyser (Instrumentation Laboratory, Warrington, UK) which has a 0-75 cm pathlength cuvette, at a wavelength of 340nm and a temperature of 37°C. A sample volume of 20 pL of an appropriately diluted urine plus 74 pL of borate/KCI assay buffer was dispensed into the inner compartment with 200 pL of working antibody particle reagent into the outer compartment of the rotor. The reaction was monitored over an 8 min period.
RESULTS
Antibody loading on particle
Excess antibody loading results in non-specific aggregation whilst insufficient antibody loading results in a lower signal. Antibody was coupled to 1% particle reagent at concentrations of 1 .O-4 -0 mg/mL and a calibration curve established using each antibody/particle reagent. The results are shown in Fig. 1 . The most sensitive standard curve with the highest equivalence point was obtained using 4 mg/mL antibody/particle reagent.
Effect of buffer type and polyethylene glycol
The molarity and pH used in this assay were chosen on the basis that they provided the optimal conditions in other previously studied latex enhanced
The effect of PEG 8000 on the rate of reaction was optimized at a final concentration of 20 g/L.
Method validation Reagent stability
Urine quality assurance pools, at three concentrations 0.57 mg/L, 1.71 mg/L and 4.61 mg/L (a gift from SCIPAC UK Ltd, Sittingbourne, UK) were aliquoted and stored at 4°C. Each pool was assayed 15 times over a 60 day period using one single working dilution of antibody/particle reagent stored at 4°C between assays. This study was performed on the Multistat I11 microcentrifugal analyser, which has a 0-5 cm pathlength cuvette (Instrumentation Laboratory, Warrington, UK) and used a different lot of particle reagent to the method development work. The coefficients of variation (CVs) calculated from the standard curve generated on day 1 for each of the low, medium and high controls were 13.8%, 5.8% and 5-8%, respectively, and CVs calculated from the standard curve generated on each day of the study were 14.5%. 5.4% and 3.6%, respectively. Thus PETIA shows a reagent stability in excess of 8 weeks.
Recovery of RBP from normal and proteinuric urine
Analytical recovery was assessed in 27 different human urine specimens with total protein concentrations ranging from less than 0-1 g/L (normal) up to 6 g/L (grossly proteinuric) by adding purified RBP to the urines to increase the RBP concentrations by 2 -5 mg/L and 5.0mg/L. In order to assess performance at the upper limit of the reference range, analytical recovery was also assessed in four normal urine samples using a much lower concentration of RBP (0.2 mg/L). The analytical recovery in these studies was 85-109% ( Table 1) .
Imprecision
Both within run and between run imprecision were determined using the above urine quality control material at three concentration levels over a period of 2 weeks. Within batch CVs for 10 determinations at three levels (mean concentrations 0-57, 1-71, 4-61 mg/L) were all less than USA). No lack of parallelism was observed in any instance.
Assay detection limit
To ascertain the detection limit of the assay 10 replicates of the zero standard (saline/Brij) and the lowest standard (0-1 mg/L) were analysed. The detection limit (calculated as 3 standard deviations above the mean absorbance change for the zero standard) was found to be 25 pg/L.
Method comparison
A total of 120 urine specimens covering a wide range of RBP levels were analysed using the PETIA and an RIA method described by Beetham et al. (1986) ' and the results compared (Fig. 2) . Latex=0.89 RIA-0.11; r = 0 -9 5 , n=120, P = <0-01.
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DISCUSSION
perform a full calibration curve each time an assay is performed, thus saving on calibrant and antibody usage. Assay sensitivity is often calculated as 3 SD above the zero standard, as described here. Although this is generally now regarded as a meaningless assessment of an assay's utility, it at least allows some comparison to be made with earlier assays. We would recommend the use of precision profiles to describe an assay performance but we could not do this for this assay as we performed our assay in singlicate. Thus our assessment of within assay CV is based on singleton measurement vs the duplicate measurement in ELISAs and RIAs. If we used duplicate measurement our CV would be improved by l/d2 as would our detection limit.
Using RBP as a model analyte for PETIA assays the detection limit, calculated as 3 SD above the zero standard, is 25pg/L (approximately 1 nmol/L) over 8 min. When comparing the detection limits in the neat urine sample for other RBP methodologies with their respective reaction times; RIA (24 nmol/L over 24 h), ELISA (0.20 nmol/L over 3 h)," PACIA (1 pmol/L over 30 min), the PETIA is seen to be a highly sensitive and more rapid assay. Sensitivity may be further increased by approximately 30% by increasing sample volume to 30 pL yielding a detection limit as low as 700 pmol/L or 500 pmol/L if assayed in duplicate. When compared with other latex enhanced assays, e.g. &n, CRP and urine albumin (detection limits in the nanomolar range),I4-l6 the RBP method, described here, which shows sensitivity at sub-nanomolar levels, extends the concentrations achievable with particle enhanced assays.
The use of a covalent coupling technique and the storage of particle reagent in glycine buffer to maintain stable particle dispersions and prevent non specific agglutination has enabled the development of a sensitive method for the rapid measurement of RBP in urine.
The urinary excretion of low molecular weight proteins reflects the reabsorptive capacity of proximal tubules when the glomerular filtration rate is normal or only slightly abnormal. Thus urinary excretion of RBP cannot be directly related to the serum concentrations of RBP, the major part of which forms a complex with prealbumin which cannot be filtered through the glomerulus.
In view of the high concentration of serum proteins found in the urine of patients with nephrotic syndrome, it is possible that these could interfere in the assay. However, Bernard et al. found that the major part of the urinary RBP is in the free form, even in patients with massive glomerular p r o t e i n~r i a .~ Thus it is essentially the unbound form of RBP that is measured in the urine. Our recovery experiments using highly proteinuric urines demonstrate quantitative recovery of RBP, suggesting that there is no interference from serum proteins in the assay. However, we have not demonstrated experimentally whether the PETIA measures total or free RBP. Good analytical recoveries at low urine RBP concentration (0.2 mg/L) were observed suggesting that the use of kinetic analysis for the method corrects adequately for any background interference in urine.
A different lot of particle reagent was used for the stability study on the Multistat than for the imprecision study performed on the Monarch. Running the assay on the Monarch 2000 (which has more precise optics) is reflected in the improved between assay precision.
The method comparison demonstrates that the PETIA agrees well with an established RIA method. The 10Vo difference in values, shown by the slope of the regression line (0-89), lies within the range expected due to experimental error, small differences in calibrator assignment and assay imprecision. Cross-calibration of the RIA with the SCIPAC standards demonstrated an 8% difference in calibrator potency (SCIPAC > RIA calibrator).
The anti-RBP antibody is covalently coupled to latex particles for long term reagent stability and stored in glycine buffer. We have previously demonstrated, using a similar protocol for latex particle reagent preparation, that assays for &m, CRP and albumin show excellent reagent stability over several months.'"I6 The preliminary stability study reported here, of a few weeks, shows similar trends. A stable working reagent not only achieves excellent precision but also obviates the need to
